Joel Greenblatt acquired 163k Biogen shares worth $23M. That's 0.13% of their equity portfolio (160th largest holding). The first Biogen trade was made in Q4 2010. Since then Joel Greenblatt bought shares 24 more times and sold shares on 25 occasions. The investor's estimated purchase price is $26.4M, resulting in a loss of 13%.